Prostate Changes | Kidney Cancer Survival | Childhood Glioma, 06/05/2024

Having trouble viewing this email? View it as a Web page.

Cancer Information Highlights From the National Cancer Institute Updating you about cancer causes, prevention, screening, treatment, coping, and more   New from NCI Understanding Prostate Changes and Conditions   This updated page explains prostate changes and symptoms that are not cancer. It also covers risk factors and treatments for benign conditions and prostate cancer, plus questions to ask your doctor. Read More About Prostate Changes Adjuvant Keytruda Improves Kidney Cancer Survival   In a large clinical trial, treatment with pembrolizumab (Keytruda) after surgery helped people with kidney cancer live longer than those who got a placebo and standard monitoring. The findings mark the first time an adjuvant treatment for kidney cancer has improved survival. Read More About Pembrolizumab and Kidney Cancer Targeted Therapy Approved for Some Children with Low-Grade Glioma   The Food and Drug Administration (FDA) granted accelerated approval to tovorafenib (Ojemda) for kids 6 months or older who have low-grade glioma, a type of brain tumor, with changes in a gene called BRAF. Read More About This New Treatment for Kids Penile Cancer Treatment Cancer of the penis is rare. Learn about penile cancer on this recently updated page, including its causes and risk factors, symptoms, diagnosis, and treatment options. Read More About Penile Cancer FDA Approves Selpercatinib for More Types of Cancers FDA recently granted accelerated approval to selpercatinib (Retevmo) for people 2 years and older who have medullary thyroid cancer, thyroid cancer, or a solid tumor that has spread and has a change in a gene called RET. Read More About Selpercatinib   Contact Us   Information specialists at NCI's Cancer Information Service (CIS), NCI's contact center, are available to help answer your cancer-related questions in English and Spanish. This page tells you how to reach us by phone, chat, or email.

Stay Connected with the National Cancer Institute
Chat with us: LiveHelp  Call us: 1-800-4-CANCER (1-800-422-6237) SUBSCRIBER SERVICES: Manage Subscriptions  |  Help

 

This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892